Thoracic Endovascular Aortic Repair Practice in 13 Countries: A Report From VASCUNET and the International Consortium of Vascular Registries
- PMID: 33214448
- DOI: 10.1097/SLA.0000000000004561
Thoracic Endovascular Aortic Repair Practice in 13 Countries: A Report From VASCUNET and the International Consortium of Vascular Registries
Abstract
Objective: To assess practice patterns and short-term outcome after thoracic endovascular aortic repair (TEVAR), based on an international vascular registry collaboration.
Summary background data: TEVAR has become the primary surgical treatment modality for descending aortic pathologies, and has expanded to new patient cohorts, including the elderly.
Methods: Data on thoracic aortic aneurysms (TAA), type B aortic dissections (TBAD), and traumatic aortic injuries (TAI) treated with TEVAR from 2012 to 2016 were retrieved from registries and centers in 13 countries.
Results: Nine-thousand five-hundred eighteen TEVAR for TAA ( n = 4436), TBAD ( n = 3976) and TAI ( n = 1106) were included. The distribution of TEVAR procedures per pathology varied, with TAA repair constituting from 40% of TEVARs in the US to 72% in the UK ( P < 0.001).Mean intact TAA (iTAA) diameter varied from 59 (US) to 69 mm (Nancy, France) ( P < 0.001), 25.3% of patients having a diameter of <60 mm. Perioperative mortality after iTAA repair was 4.9%; combined mortality, stroke, paraplegia, and renal replacement therapy outcome was 12.8%. 18.6% of iTAA patients were ≥80 years old. Mortality was higher in this group (7.2%) than in patients <80 (3.8%) ( P < 0.001). After rTAA repair, perioperative mortality was 26.8%.Mortality was 9.7% after acute (within 14 days from onset of dissection) and 3.0% after chronic TBAD repair ( P < 0.001). Mortality after TAI was 7.8%, and depended on injury severity (grade IV (free rupture) 20.9%).
Conclusions: This registry collaboration provides a unique platform to evaluate cross-border patterns of use and outcomes of TEVAR. A common core dataset is proposed, to achieve harmonization of registry-based quality outcome measures for TEVAR.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest and source of funding: AWB: Contracted research: Cook Medical; Medtronic, Inc.; Terumo Aortic; W.L. Gore & Associates. Consulting: Cook Medical, Cryolife, Medtronic, Inc.; Terumo Aortic. KM: Consulting: Cook Medical Inc., Institutional funds: Cook Medical Inc. and Gore Medical.
References
-
- Volodos NL. Historical perspective: the first steps in endovascular aortic repair: how it all began. J Endovasc Ther. 2013;20(Supp 1):13–23.
-
- Virtue Registry Investigators. Mid-term outcomes and aortic remodelling after thoracic endovascular repair for acute, subacute, and chronic aortic dissection: the VIRTUE Registry. Eur J Vasc Endovasc Surg. 2014;48:363–371.
-
- Lombardi JV, Cambria RP, Nienaber CA, et al. Five-year results from the Study of Thoracic Aortic Type B Dissection Using Endoluminal Repair (STABLE I) study of endovascular treatment of complicated type B aortic dissection using a composite device design. J Vasc Surg. 2019;70:1072–1081. e1072.
-
- Riambau V, Bockler D, Brunkwall J, et al. Editor’s choice - management of descending thoracic aorta diseases: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017;53:4–52.
-
- Geisbusch S, Kuehnl A, Salvermoser M, et al. Increasing incidence of thoracic aortic aneurysm repair in germany in the endovascular era: secondary data analysis of the Nationwide German DRG Microdata. Eur J Vasc Endovasc Surg. 2019;57:499–509.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
